"The biotech industry is a complex, rapidly evolving, and critical industry. The industry holds great commercial and societal promise, but it is also filled with hype, confusion, and risks. Bergeron and Chan do a remarkable job of providing a sweeping insightful, and probing assessment of the current state and likely evolution of this global industry. This book is essential reading for the executive who desires a thorough understanding of this business and its potential."--John P. Glasser, Vice President and Chief Information Offers, Partners Healthcare System, Inc.
"Bergeron and Chan...

This volume accompanies the first major solo exhibition on American artist Paul Chan (born 1973) since his series The 7 Lights was presented at the New Museum in 2008. Chan is one of the most versatile and unpredictable artists of his generation, and certainly one of the most original voices in contemporary art today. Active as artist, writer and publisher, he engages the viewer in a challenging discourse about the place of art in social and political life. Chan's combination of old and new works casts new light on the content and complexity of his fascinating art. In addition to early...